DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User - Global Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering.

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%.

Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel the growth of this market.

However, end-user budget constraints in developing nations are expected to restrain the growth of the next-generation sequencing market in the forecast period.

The next-generation sequencing market, by technology, is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies. The sequencing by synthesis segment is expected to command the largest share of the next-generation sequencing market in 2018.

The large share of this segment can be attributed to the continuous advancements in SBS technology-based consumables and NGS bioinformatics solutions as well as the launch of advanced cost- & time-efficient platforms based on SBS technology.

On the basis of end user, the next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment is estimated to witness the highest growth rate during the forecast period.

The high growth in this segment can be attributed to the development of advanced NGS-based diagnostic solutions and growing number of agreements between companies and hospitals for developing advanced tests and products catering to the specific needs of hospitals and clinics.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Next-Generation Sequencing Market, By Product & Service

7 Next-Generation Sequencing Market, By Technology

8 Next-Generation Sequencing Market, By Application

9 Next-Generation Sequencing Market, By End User

10 Next-Generation Sequencing Market, By Region

11 Competitive Landscape

12 Company Profiles

10x Genomics Agilent Technologies, Inc. Beckman Coulter (A Subsidiary of Danaher) Becton, Dickinson and Company BGI Eurofins Scientific F. Hoffmann-La Roche AG Genewiz Illumina, Inc. Macrogen, Inc. Oxford Nanopore Technologies, Ltd. Pacific Biosciences of California, Inc. Perkinelmer, Inc. Qiagen N.V. Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/j8gs4g/nextgeneration?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005469/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Bioinformatics,Molecular Diagnostics

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/29/2018 10:28 AM/DISC: 08/29/2018 10:28 AM

http://www.businesswire.com/news/home/20180829005469/en